Search filters

Filters
Clear All

Phase

  • 11
  • 38
  • 28
  • 46
  • 6
  • 50
  • 9
  • 278
  • 490
  • 158
  • 4
  • 31
  • 457
  • 486
  • 6
  • 4
  • 488

Found 492 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
UPCC 12420 A Phase 2, Open- Label, Single-Arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (NHL)
18 years or above
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in adults with relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma (NHL), specifically follicular lymphoma (FL) and marginal zone lymphoma (MZL). The purpose of this study is to understand how well the investigational medication works in treating these types of …
99 years or below
All genders
This study will: -- Collect tissue and body fluid specimens for immediate analysis and short-term storage while protecting the confidentiality of individuals undergoing resection of soft tissue sarcoma and GIST -- Correlate relevant clinical characteristics for the identification of significant tumor and immune cell markers that may have impact on …
99 years or below
All genders
To determine if blood biomarkers are associated with the development of cancer or cancer recurrence or the development of late effects of interventions to decrease cancer risk (such as prophylactic oophorectomy) in individuals at high risk for the development of breast, ovarian, pancreatic and other cancers based on family history …
18 years or above
All genders
Phase 3
Interventional
This study investigates how effective one year versus two years of maintenance therapy is for patients with advanced ovarian cancer that has BRCA1/2 mutations or is homologous recombination deficient (HRD+). The purpose is to compare the effects of using the investigational medication, olaparib, with or without an antiangiogenic agent, bevacizumab, …
CHARM- Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema following Large Hemispheric Infarction
18 years - 99 years
All genders
Phase 3
Interventional
This is a Phase 3 study, which means that BIIB093 (study drug) has already been investigated in previous clinical research studies with a small number of people with large hemispheric infarction (LHI). These studies suggested that the study drug was safe, did not cause serious side effects or discomfort, and …
18 years or above
All genders
Interventional
This study investigates the use of behavioral economics and implementation science to improve the delivery of genomic medicine within a diverse health system. The purpose of this study is to explore how non-geneticist clinicians and patients can be encouraged, through nudges, to utilize genetic testing in situations where it can …
All genders
Phase 2
Interventional
This study investigates how genetic testing can guide cancer treatment choices for patients with advanced solid tumors. The purpose is to use the genetic information from patients' tumor cells to match them with investigational combination therapies that target specific genetic mutations. This approach aims to control tumor growth and improve …
18 years or above
All genders
Observational
This study investigates the impact of refractory ascites on health-related quality of life and sarcopenia. The purpose of this study is to use new survey tools to measure changes in quality of life for patients with this condition.Participants will complete quality of life questionnaires at the start of the study, …
99 years or below
All genders
Single patient compassionate use protocol. Received palliative first-line treatment with FOLFIRINOX/FOLFIRI from 6/2017 through 4/2018 at which time her disease remained stable. The patient was suffering from cumulative chemotherapy toxicities and therefore elected to enroll in UPCC 35217, a trial of maintenance niraparib with either nivolumab or ipilimumab in patients …
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and effectiveness of combining two investigational medications, SNDX-5613 and gilteritinib, for treating relapsed or refractory acute myeloid leukemia (AML) with specific genetic mutations. This study focuses on patients whose leukemia has returned or not responded to treatment and who have mutations in the FLT3 gene, …
361 - 370 of 492